This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burns, J. M.
Right arrow Articles by Dunn, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burns, J. M., Jr.
Right arrow Articles by Dunn, P. D.

 Previous Article  |  Next Article 

Infection and Immunity, February 1999, p. 675-680, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Protective Immunization with a Novel Membrane Protein of Plasmodium yoelii-Infected Erythrocytes

James M. Burns Jr.,* Eric K. Adeeku, and Patricia D. Dunn

Department of Microbiology, Meharry Medical College, Nashville, Tennessee 37208

Received 24 August 1998/Returned for modification 5 October 1998/Accepted 11 November 1998

Immunization with a particulate fraction of blood-stage antigens was shown previously to protect mice against Plasmodium yoelii malaria. To identify antigens inducing the protective response, sera from immunized mice were used to screen a P. yoelii cDNA expression library. Sequence analysis of one 2.6-kb cDNA clone indicated that the identified gene, pypag-1, encoded a novel plasmodial antigen. Two nonoverlapping regions of pypag-1 were expressed in Escherichia coli. The first recombinant antigen, pAg-1N, contained the N-terminal 337 residues, which included a putative transmembrane domain and a region relatively rich in tryptophan residues. The second recombinant antigen, pAg-1C, contained the remaining C-terminal 211 residues, which included 31 copies of a 5-amino-acid degenerative repeat. Immunoblot studies using rabbit antiserum raised against recombinant pAg-1N showed that the native pypAg-1 protein migrated at approximately 98 kDa, considerably slower than its predicted molecular mass of 66 kDa. Immunofluorescence studies localized the expression of the native pypAg-1 protein both to the cytoplasm and at the surface of P. yoelii-infected erythrocytes. Immunization with either pAg-1N or pAg-1C induced a four- to sevenfold reduction in P. yoelii blood-stage parasitemia. As such, pypAg-1 appears to contain at least two distinct protective epitopes. To our knowledge, this is the first characterization of a protective antigen of P. yoelii that is associated with the erythrocyte membrane.


* Corresponding author. Mailing address: Meharry Medical College, Department of Microbiology, 1005 D.B. Todd Blvd., Nashville, TN 37208. Phone: (615) 327-5726. Fax: (615) 327-6072. E-mail: burnsj31{at}ccvax.mmc.edu.


Infection and Immunity, February 1999, p. 675-680, Vol. 67, No. 2
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Siddiqui, A. A., Bora, H., Singh, N., Dash, A. P., Sharma, Y. D. (2008). Expression, Purification, and Characterization of the Immunological Response to a 40-Kilodalton Plasmodium vivax Tryptophan-Rich Antigen. Infect. Immun. 76: 2576-2586 [Abstract] [Full Text]  
  • Burns, J. M. Jr., Belk, C. C., Dunn, P. D. (2000). A Protective Glycosylphosphatidylinositol-Anchored Membrane Protein of Plasmodium yoelii Trophozoites and Merozoites Contains Two Epidermal Growth Factor-Like Domains. Infect. Immun. 68: 6189-6195 [Abstract] [Full Text]